Chief Science Officer

Bio is a decentralized science protocol that helps launch and grow AI-driven biotech research. It enables scientists to raise funds, create value from their work, and distribute that value directly to their communities. Since 2023, Bio has directed over $50m to global researchers, offering an alternative to traditional pharma funding. Backed by investors like Binance Labs, Northpond Ventures, and Animoca Brands, Bio accelerates real-world therapeutics across longevity, brain health, fertility, psychedelic science, and more. Why this role exists Bio is entering a phase where scientific ambition must deliver repeatable, credible outcomes at portfolio scale. We need senior leadership to evaluate, prioritize, and support multiple assets while improving the systems that guide scientific decisions. The CSO will own Bio's scientific direction at the portfolio level - ensuring that promising ideas are rigorously evaluated, translated into testable programs, and moved into labs. The right person brings deep scientific credibility, experience with drug development, and the ability to attract and guide top-tier researchers. A key requirement is meaningful exposure to the drug development and approval process - having observed programs through preclinical, IND-enabling, clinical, and regulatory stages. What the CSO will actually do 1. Own Bio’s portfolio-level scientific direction Review projects launching on Bio Protocol, maintain a clear portfolio view of what's strongest and most prom